Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance

被引：13

作者：

Aggen, David H. ^{[1
]}

Chu, Carissa E. ^{[2
]}

Rosenberg, Jonathan E. ^{[1
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA

来源：

CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 08期

关键词：

UROTHELIAL CANCER; AGENT;

D O I：

10.1158/1078-0432.CCR-22-3882

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Clinical data with enfortumab vedotin (EV) suggest that most bladder cancers overexpress NECTIN-4. A recent article shows that NECTIN-4 membranous expression changes with progression to metastatic disease and that low NECTIN-4 expression in metastatic biopsies is potentially associated with EV resistance. These data argue for incorporation of NECTIN-4 expression into future biomarker strategies.

引用

页码：1377 / 1380

页数：4

共 19 条

[11] Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance [J].

Kluemper, Niklas ;

Ralser, Damian J. ;

Ellinger, Joerg ;

Roghmann, Florian ;

Albrecht, Julia ;

Below, Eduard ;

Alajati, Abdullah ;

Sikic, Danijel ;

Breyer, Johannes ;

Bolenz, Christian ;

Zengerling, Friedemann ;

Erben, Philipp ;

Schwamborn, Kristina ;

Wirtz, Ralph M. ;

Horn, Thomas ;

Nagy, Dora ;

Toma, Marieta ;

Kristiansen, Glen ;

Buettner, Thomas ;

Hahn, Oliver ;

Gruenwald, Viktor ;

Darr, Christopher ;

Erne, Eva ;

Rausch, Steffen ;

Bedke, Jens ;

Schlack, Katrin ;

Abbas, Mahmoud ;

Zschaebitz, Stefanie ;

Schwab, Constantin ;

Mustea, Alexander ;

Adam, Patrick ;

Manseck, Andreas ;

Wullich, Bernd ;

Ritter, Manuel ;

Hartmann, Arndt ;

Gschwend, Jurgen ;

Weichert, Wilko ;

Erlmeier, Franziska ;

Hoelzel, Michael ;

Eckstein, Markus .

CLINICAL CANCER RESEARCH, 2023, 29 (08) :1496-1505

[12] TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells [J].

Mariathasan, Sanjeev ;

Turley, Shannon J. ;

Nickles, Dorothee ;

Castiglioni, Alessandra ;

Yuen, Kobe ;

Wang, Yulei ;

Kadel, Edward E., III ;

Koeppen, Hartmut ;

Astarita, Jillian L. ;

Cubas, Rafael ;

Jhunjhunwala, Suchit ;

Banchereau, Romain ;

Yang, Yagai ;

Guan, Yinghui ;

Chalouni, Cecile ;

Ziai, James ;

Senbabaoglu, Yasin ;

Santoro, Stephen ;

Sheinson, Daniel ;

Hung, Jeffrey ;

Giltnane, Jennifer M. ;

Pierce, Andrew A. ;

Mesh, Kathryn ;

Lianoglou, Steve ;

Riegler, Johannes ;

Carano, Richard A. D. ;

Eriksson, Pontus ;

Hoglund, Mattias ;

Somarriba, Loan ;

Halligan, Daniel L. ;

van der Heijden, Michiel S. ;

Loriot, Yohann ;

Rosenberg, Jonathan E. ;

Fong, Lawrence ;

Mellman, Ira ;

Chen, Daniel S. ;

Green, Marjorie ;

Derleth, Christina ;

Fine, Gregg D. ;

Hegde, Priti S. ;

Bourgon, Richard ;

Powles, Thomas .

NATURE, 2018, 554 (7693) :544-+

[13]

Petrylak DP, 2022, J CLIN ONCOL, V40, p6s

[14] Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with Nectin1/PRR1 through V domain interaction [J].

Reymond, N ;

Fabre, S ;

Lecocq, E ;

Adelaïde, J ;

Dubreuil, P ;

Lopez, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :43205-43215

[15] Study EV-103 Cohort K: Antitumor activity of enfortumab vedotin (EV) monotherapy or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) [J].

Rosenberg, J. E. ;

Milowsky, M. ;

Ramamurthy, C. ;

Mar, N. ;

Mckay, R. R. ;

Friedlander, T. ;

Ferrario, C. ;

Bracarda, S. ;

George, S. ;

Moon, H. ;

Geynisman, D. ;

Petrylak, D. P. ;

Borchiellini, D. ;

Burgess, E. F. ;

Rey, J. P. Maroto ;

Carret, A-S. ;

Yu, Y. ;

Guseva, M. V. ;

Moreno, B. Homet ;

O'Donnell, P. H. .

ANNALS OF ONCOLOGY, 2022, 33 (07) :S1441-S1441

[16] EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma [J].

Rosenberg, Jonathan ;

Sridhar, Srikala S. ;

Zhang, Jingsong ;

Smith, David ;

Ruether, Dean ;

Flaig, Thomas W. ;

Baranda, Joaquina ;

Lang, Joshua ;

Plimack, Elizabeth R. ;

Sangha, Randeep ;

Heath, Elisabeth I. ;

Merchan, Jamie ;

Quinn, David I. ;

Srinivas, Sandy ;

Milowsky, Matthew ;

Wu, Chunzhang ;

Gartner, Elaina M. ;

Zuo, Peiying ;

Melhem-Bertrandt, Amal ;

Petrylak, Daniel P. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (10) :1041-+

[17] Tumor mutational load predicts survival after immunotherapy across multiple cancer types [J].

Samstein, Robert M. ;

Lee, Chung-Han ;

Shoushtari, Alexander N. ;

Hellmann, Matthew D. ;

Shen, Ronglai ;

Janjigian, Yelena Y. ;

Barron, David A. ;

Zehir, Ahmet ;

Jordan, Emmet J. ;

Omuro, Antonio ;

Kaley, Thomas J. ;

Kendall, Sviatoslav M. ;

Motzer, Robert J. ;

Hakimi, A. Ari ;

Voss, Martin H. ;

Russo, Paul ;

Rosenberg, Jonathan ;

Iyer, Gopa ;

Bochner, Bernard H. ;

Bajorin, Dean F. ;

Al-Ahmadie, Hikmat A. ;

Chaft, Jamie E. ;

Rudin, Charles M. ;

Riely, Gregory J. ;

Baxi, Shrujal ;

Ho, Alan L. ;

Wong, Richard J. ;

Pfister, David G. ;

Wolchok, Jedd D. ;

Barker, Christopher A. ;

Gutin, Philip H. ;

Brennan, Cameron W. ;

Tabar, Viviane ;

Mellinghoff, Ingo K. ;

DeAngelis, Lisa M. ;

Ariyan, Charlotte E. ;

Lee, Nancy ;

Tap, William D. ;

Gounder, Mrinal M. ;

D'Angelo, Sandra P. ;

Saltz, Leonard ;

Stadler, Zsofia K. ;

Scher, Howard I. ;

Baselga, Jose ;

Razavi, Pedram ;

Klebanoff, Christopher A. ;

Yaeger, Rona ;

Segal, Neil H. ;

Ku, Geoffrey Y. ;

DeMatteo, Ronald P. .

NATURE GENETICS, 2019, 51 (02) :202-+

[18] Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer [J].

Seiler, Roland ;

Gibb, Ewan A. ;

Wang, Natalie Q. ;

Oo, Htoo Zarni ;

Lam, Hung-Ming ;

van Kessel, Kim E. ;

Voskuilen, Charlotte S. ;

Winters, Brian ;

Erho, Nicholas ;

Takhar, Mandeep M. ;

Douglas, James ;

Vakar-Lopez, Funda ;

Crabb, Simon J. ;

van Rhijn, Bas W. G. ;

van de Putte, Elisabeth E. Fransen ;

Zwarthoff, Ellen C. ;

Thalmann, George N. ;

Davicioni, Elai ;

Boormans, Joost L. ;

Dall'Era, Marc ;

Van der Heijden, Michiel S. ;

Wright, Jonathan L. ;

Black, Peter C. .

CLINICAL CANCER RESEARCH, 2019, 25 (16) :5082-5093

[19] Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial [J].

Yu, Evan Y. ;

Petrylak, Daniel P. ;

O'Donnell, Peter H. ;

Lee, Jae-Lyun ;

van der Heijden, Michiel S. ;

Loriot, Yohann ;

Stein, Mark N. ;

Necchi, Andrea ;

Kojima, Takahiro ;

Harrison, Michael R. ;

Park, Se Hoon ;

Quinn, David, I ;

Heath, Elisabeth, I ;

Rosenberg, Jonathan E. ;

Steinberg, Joyce ;

Liang, Shang-Ying ;

Trowbridge, Janet ;

Campbell, Mary ;

McGregor, Bradley ;

Balar, Arjun, V .

LANCET ONCOLOGY, 2021, 22 (06) :872-882

← 1 2 →